FSCN1 and intrahepatic cholangiocarcinoma: This study selected 108 cases of HCC, 26 cases of ICC, 23 cases of liver cirrhosis, and 11 cases of normal liver tissue to elucidate the expression of FSCN1 in liver tissue and its clinicopathological significance in the occurrence and development of liver cancer.